[2,3′-Bipyridin]-6′(1’H)-one, 5′-bromo- – (381233-79-0)

mitotane, 53-19-0, Mitotan, Lysodren, o, p'-DDD, Chlodithane, Chloditan, Khlodithan, Chlodithan, Mitotano, 2, 4'-Ddd, 1-(2-Chlorophenyl)-1-(4-chlorophenyl)-2, 2-dichloroethane, o, p'-TDE, Opeprim, Mitotanum, 1-Chloro-2-[2, 2-dichloro-1-(4-chlorophenyl)ethyl]benzene, 2, 4'-Dichlorodiphenyldichloroethane, NCI-C04933, 1-Chloro-2-(2, 2-dichloro-1-(4-chlorophenyl)ethyl)benzene, CB 313, Benzene, 1-chloro-2-[2, 2-dichloro-1-(4-chlorophenyl)ethyl]-, o, p'-Dichlorodiphenyldichloroethane, 2, 4'-Dichlorophenyldichlorethane, CB-313, NSC-38721, O, p'-ddd, o p'-tde, 1, 1-Dichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane, (o, p)-DDD, 2-(2-Chlorophenyl)-2-(4-chlorophenyl)-1, 1-dichloroethane, NSC38721, NSC 38721, 2, 2-Bis(2-chlorophenyl-4-chlorophenyl)-1, 1-dichloroethane, 2-(o-Chlorophenyl)-2-(p-chlorophenyl)-1, 1-dichloroethane, Mitotane (Lysodren), 78E4J5IB5J, Benzene, 1-chloro-2-(2, 2-dichloro-1-(4-chlorophenyl)ethyl)-, 1, 1-Dichloro-2, 2-bis(2, 4'-dichlorophenyl)ethane, 1, 1-Dichloro-2-(p-chlorophenyl)-2-(o-chlorophenyl)ethane, MFCD00000850, (2, 4'-Dichlorodiphenyl)dichloroethane, Ethane, 2-(o-chlorophenyl)-2-(p-chlorophenyl)-1, 1-dichloro-, DTXSID9020372, Khloditan, Mytotan, Ethane, 1, 1-dichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)-, ortho, para-DDD, Mitotanum [INN-Latin], o, p-Tde, NCGC00015226-07, 1-chloro-4-[2, 2-dichloro-1-(2-chlorophenyl)ethyl]benzene, 2, 4'-DDD 10 microg/mL in Cyclohexane, 2, 4'-DDD 100 microg/mL in Cyclohexane, MITOTANE (MART.), MITOTANE [MART.], MITOTANE (USP-RS), MITOTANE [USP-RS], ortho, para DDD, Mitotano [INN-Spanish], DTXCID30372, 2, 4'-DDD o, p'-DDD, MITOTANE (USP IMPURITY), MITOTANE [USP IMPURITY], MITOTANE (USP MONOGRAPH), MITOTANE [USP MONOGRAPH], CB313, (+/-)-1, 1-DICHLORO-2-(O-CHLOROPHENYL)-2-(P-CHLOROPHENYL)ETHANE, DDD, o, p'-, BENZENE, 1-CHLORO-2-(2, 2-DICHLORO-1-(4-CHLOROPHENYL)ETHYL)-, (+/-)-, CAS-53-19-0, Lysodren (TN), SMR000326696, CCRIS 4397, HSDB 3240, SR-01000075751, EINECS 200-166-6, Mitotane (JAN/USP/INN), BRN 2056007, UNII-78E4J5IB5J, Lisodren, AI3-07575, Prestwick_75, Ethane, 1-dichloro-, Mitotane (Standard), Mitotane [USAN:USP:INN:BAN:JAN], 1-chloro-2-, Spectrum_001959, MITOTANE [HSDB], MITOTANE [USAN], DDD-o, p', MITOTANE [INN], MITOTANE [JAN], o.p.-TDE, MITOTANE [MI], MITOTANE [VANDF], (+-)-1, 1-Dichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane, Spectrum2_000916, Spectrum3_000869, Spectrum4_000709, Spectrum5_002060, MITOTANE [WHO-DD], C 3010, (o, p')-DDD, SCHEMBL4040, CHEMBL1670, MITOTANE [EMA EPAR], Lopac0_000251, WLN: GYGYR BG&R DG, BSPBio_002517, KBioGR_001237, KBioSS_002513, SPECTRUM330082, Mitotane – Bio-X trade mark, MLS001335899, MLS001335900, MLS002152914, MLS002153233, 2, 4-DDD o, p'-DDD, DivK1c_000703, SPBio_000792, MITOTANE [ORANGE BOOK], CHEBI:6954, GTPL6957, Mitotane, >=98% (HPLC), HMS502D05, KBio1_000703, KBio2_002505, KBio2_005073, KBio2_007641, KBio3_002017, L01XX23, NINDS_000703, HMS1923K19, HMS2091E07, HMS2232C16, HMS3260D04, HMS3369H10, HMS3655G06, HMS3715H07, HMS3869F13, Pharmakon1600-00330082, BCP11663, LAC39621, MSK20508, 2, 4 inverted exclamation marka-DDD, Tox21_110103, Tox21_302804, Tox21_500251, 2, 4'-Dichlorodiphenyldichloroethane, CCG-40014, HY-13690R, NSC755849, s1732, 1, 2-bis(2, 4'-dichlorophenyl)ethane, AKOS006028802, Benzene, 1-chloro-2-(2, 2-dichloro-1-(4-chlorophenyl)ethyl)-, (+-)-, Tox21_110103_1, CS-1500, DB00648, FM02907, LP00251, NSC-755849, SDCCGSBI-0050239.P006, IDI1_000703, NCGC00015226-02, NCGC00015226-03, NCGC00015226-04, NCGC00015226-05, NCGC00015226-06, NCGC00015226-08, NCGC00015226-09, NCGC00015226-10, NCGC00015226-11, NCGC00015226-12, NCGC00091374-01, NCGC00091374-02, NCGC00091374-03, NCGC00091374-04, NCGC00091374-05, NCGC00091374-06, NCGC00256452-01, NCGC00260936-01, AS-11690, BM300096, HY-13690, NCI60_003688, WR-13045, SBI-0050239.P004, O, P'-DICHLORODIPHENYL-DICHLOROETHANE, EU-0100251, M3304, NS00009562, SW199619-3, EN300-37268, 2, 4 inverted exclamation marka-DDD o, p'-DDD, 2, 4'-DDD, PESTANAL(R), analytical standard, C75491, D00420, AB00052337-09, AB00052337_10, Q417465, 1, 1, -Dichloro-2, 2-bis(2, 4-dichlorophenyl)ethane, SR-01000075751-1, SR-01000075751-3, SR-01000075751-6, BRD-A31204924-001-13-4, BRD-A31204924-001-14-2, BRD-A31204924-001-16-7, BRD-A31204924-001-17-5, 2, 4'-(2, 2-dichloroethane-1, 1-diyl)bis(chlorobenzene), Z381079728, 1, 1-Dichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane, 1-(o-Chlorophenyl)-1-(p-chlorophenyl)-2, 2-dichloroethane, Ethane, 1-dichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)-, 1-Chloro-2-[2, 2-dichloro-1-(4-chlorophenyl)ethyl]benzene #, 2, 2-Bis(2-chlorophenyl-4-chlorophenyl)-1, 1-dichloroethane, Mitotane, United States Pharmacopeia (USP) Reference Standard, 1-CHLORO-2-(2, 2-DICHLORO-1-(4-CHLOROPHENYL))ETHYLBENZENE, 2(O-CHLOROPHENYL)-2-(P-CHLOROPHENYL)-1, 1-DICHLOROETHANE, 200-166-6